The Effect of Mindfulness in Inflammation Markers (IL-6, TNF-A, CRP and Cortisol) Among Survivors of Tidal Flooding in Sayung Demak
Recurrent tidal flooding (rob) in the coastal areas of Sayung District, Demak Regency, poses a continuous environmental threat that inflicts housing damage, economic instability, and prolonged socioeconomic uncertainty on local residents. These chronic stressors frequently trigger significant psychological distress, including elevated levels of stress, anxiety, and depression, while simultaneously activating systemic inflammatory pathways and dysregulating the hypothalamic-pituitary-adrenal (HPA) axis.
Mindfulness body scan is a structured, non-pharmacological mind-body technique that involves directing non-judgmental attention to physical sensations across the body. Within a psycho-neuro-immunological framework, mindfulness practice is hypothesized to reduce physiological stress responses, promote autonomic nervous system balance, and downregulate pro-inflammatory pathways.
This randomized controlled trial evaluates the effectiveness of a structured 8-day mindfulness body scan intervention on both biological inflammatory markers and psychological outcomes among tidal flood survivors. Participants recruited from Sayung 1 Primary Health Center will be randomly allocated into two groups:
- Intervention Group: Receives structured 8-day Mindfulness Body Scan training.
- Control Group: Receives standard health monitoring. All participants will undergo baseline and post-intervention assessments, which include venous blood sampling to analyze key inflammatory and stress biomarkers-Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-α), C-Reactive Protein (CRP), and Cortisol. In addition, psychometric instruments will evaluate changes in depression, anxiety, stress, sleep quality, and overall quality of life. The primary objective is to determine whether a short-term mindfulness body scan practice can effectively reduce systemic inflammation and improve post-disaster psychological well-being in coastal communities.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Background: Recurrent tidal flooding in coastal Sayung, Demak, exposes residents to chronic environmental and socioeconomic stress, contributing to psychological distress and elevated systemic inflammation. Within a psychoneuroimmunological framework, mindfulness practices-specifically the body scan technique-may suppress pro-inflammatory pathways and regulate the hypothalamic-pituitary-adrenal (HPA) axis.
Study Design: This is a randomized controlled trial conducted at Sayung 1 Primary Health Center, Demak. Eligible adult survivors of tidal flooding will be randomly allocated to either the intervention group or the control group.
Intervention & Control:
- Intervention Group: Receives structured 8-day Mindfulness Body Scan training.
- Control Group: Receives standard health monitoring.
Assessments: Baseline and 1-week post-intervention evaluations will be conducted for all participants:
- Biomarkers: Venous blood samples to analyze Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-α), C-Reactive Protein (CRP), and Cortisol.
- Psychometric Assessments: Standardized questionnaires evaluating depression, anxiety, stress, sleep quality, and quality of life.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Natalia Dewi Wardani Dr. dr. Sp.KJ(K)
- Numero di telefono: +6281325683134
- Email: anatdew@gmail.com
Luoghi di studio
-
-
Central Java
-
Demak, Central Java, Indonesia
- Puskesmas Sayung 1
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Age 18 years or older.
- Resident of Sayung District, Demak Regency, affected by tidal flooding (rob).
- Registered patient at Sayung 1 Primary Health Center.
- Capable of providing written informed consent and participating in the intervention sessions.
Exclusion Criteria:
- Severe cognitive impairment, active psychosis, or severe psychiatric conditions preventing participation.
- Uncontrolled systemic autoimmune or inflammatory diseases.
- Current use of long-term systemic corticosteroid or immunosuppressive therapy.
- Inability to complete questionnaires or follow basic mindfulness instructions.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Mindfulness Body Scan
Participants undergo structured Mindfulness Body Scan training over an 8-day period alongside standard care
|
A structured 8-day mind-body exercise where participants systematically direct non-judgmental attention to physical sensations throughout the body from head to toe
|
|
Nessun intervento: Control Group
Participants receive standard health monitoring without the mindfulness body scan intervention
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Serum Interleukin-6 (IL-6) Levels
Lasso di tempo: Baseline (Day 0) and post-intervention (Day 8)
|
Measured from venous blood samples using ELISA to evaluate changes in pro-inflammatory cytokine levels (concentrations reported in pg/mL).
|
Baseline (Day 0) and post-intervention (Day 8)
|
|
Change in Serum Tumor Necrosis Factor-alpha (TNF-α) Levels
Lasso di tempo: Baseline (Day 0) and post-intervention (Day 8)
|
Measured from venous blood samples using ELISA to assess systemic inflammatory responses (concentrations reported in pg/mL)
|
Baseline (Day 0) and post-intervention (Day 8)
|
|
Change in Serum C-Reactive Protein (CRP) Levels
Lasso di tempo: Baseline (Day 0) and post-intervention (Day 8)
|
Evaluated via laboratory blood analysis as an indicator of acute phase systemic inflammation (concentrations reported in mg/L).
|
Baseline (Day 0) and post-intervention (Day 8)
|
|
Change in Serum Cortisol Levels
Lasso di tempo: Baseline (Day 0) and post-intervention (Day 8)
|
Measured via venous blood samples to assess HPA axis regulation and physiological stress response (concentrations reported in micro-g/dL).
|
Baseline (Day 0) and post-intervention (Day 8)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Depression Score
Lasso di tempo: Baseline (Day 0) and post-intervention (Day 8)
|
Measured using the Patient Health Questionnaire-9 (PHQ-9).
Scores range from 0 to 27, where higher scores indicate greater severity of depression.
|
Baseline (Day 0) and post-intervention (Day 8)
|
|
Change in Anxiety Score
Lasso di tempo: Baseline (Day 0) and post-intervention (Day 8)
|
Measured using the Generalized Anxiety Disorder 7-item scale (GAD-7).
Scores range from 0 to 21, where higher scores indicate greater severity of anxiety.
|
Baseline (Day 0) and post-intervention (Day 8)
|
|
Change in Stress Score
Lasso di tempo: Baseline (Day 0) and post-intervention (Day 8)
|
Measured using the Perceived Stress Scale (PSS-10).
Scores range from 0 to 40, where higher scores indicate higher levels of perceived stress.
|
Baseline (Day 0) and post-intervention (Day 8)
|
|
Change in Sleep Quality Score
Lasso di tempo: Baseline (Day 0) and post-intervention (Day 8)
|
Measured using the Pittsburgh Sleep Quality Index (PSQI).
Global scores range from 0 to 21, where higher scores indicate worse sleep quality.
|
Baseline (Day 0) and post-intervention (Day 8)
|
|
Change in Quality of Life Score
Lasso di tempo: Baseline (Day 0) and post-intervention (Day 8)
|
Measured using the 36-Item Short Form Health Survey (SF-36) Physical Component Summary.
Scores range from 0 to 100, where higher scores represent better health-related quality of life.
|
Baseline (Day 0) and post-intervention (Day 8)
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- FK-UNDIP-MIND-01
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .